---
title: "Novo Nordisk CEO: We will continue to hire as needed, but we will be more cautious in our recruitmen"
description: "Novo Nordisk CEO: We will continue to hire as needed, but we will be more cautious in our recruitment"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/256717611.md"
published_at: "2025-09-10T10:17:11.000Z"
---

# Novo Nordisk CEO: We will continue to hire as needed, but we will be more cautious in our recruitmen

> Novo Nordisk CEO: We will continue to hire as needed, but we will be more cautious in our recruitment

Novo Nordisk CEO: We will continue to hire as needed, but we will be more cautious in our recruitment

### Related Stocks

- [NVO.US - Novo Nordisk AS](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Savvy Advisors Inc. 购入了诺和诺德公司 22,138 股股票 $NVO | Savvy Advisors Inc. 在第三季度将其在诺和诺德公司（Novo Nordisk A/S）的持股增加了 83.0%，收购了 22,138 股，使其总持股达到 48,824 股，价值 270 万美元。其他机构投资者也调整了他们的 | [Link](https://longbridge.com/en/news/275761183.md) |
| 诺和诺德公司将在其爱尔兰工厂生产 Wegovy | 诺和诺德公司将在爱尔兰工厂生产 Wegovy | [Link](https://longbridge.com/en/news/275789396.md) |
| 奥本海默资产管理公司在诺和诺德公司持有价值 3135 万美元的股票头寸 | Oppenheimer Asset Management Inc. 在第三季度将其在诺和诺德公司（Novo Nordisk A/S）的持股增加了 14.4%，持有 565,007 股，价值 3135 万美元。其他机构投资者也调整了他们的持仓 | [Link](https://longbridge.com/en/news/275287765.md) |
| 诺和诺德公司计划开始销售其减肥重磅药物 Wegovy 的瓶装版本 - 彭博社 | 诺和诺德公司计划开始以小瓶形式销售其减肥畅销药 Wegovy - 彭博新闻 | [Link](https://longbridge.com/en/news/275654518.md) |
| 诺和诺德欧股暴跌 18%，CEO 坦言：2026 年遭遇 “前所未有的定价压力” | 面对市场激烈竞争与 2026 年销售下滑预期，诺和诺德 CEO 坦言明星减肥药 Wegovy 降价对财务造成 “痛苦” 影响，但旨在以价换量。为稳定信心，公司宣布启动最高 38 亿丹麦克朗的股票回购，并计划派发股息，同时寄望于新款口服 We | [Link](https://longbridge.com/en/news/274786733.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
